Filing Details
- Accession Number:
- 0001299130-15-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-11 17:12:10
- Reporting Period:
- 2015-08-07
- Filing Date:
- 2015-08-11
- Accepted Time:
- 2015-08-11 17:12:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1299130 | Pacific Biosciences Of California Inc. | PACB | Laboratory Analytical Instruments (3826) | 161590339 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1504238 | Michael James Phillips | Pacific Biosciences Of California, Inc. 1380 Willow Road Menlo Park CA 94025 | Svp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-07 | 31,663 | $0.70 | 195,849 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-08-07 | 16,689 | $4.61 | 179,160 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-07 | 31,663 | $0.00 | 31,663 | $0.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-09-08 | No | 4 | M | Direct |
Footnotes
- This is the weighted average price of the shares sold, which ranged from $4.61 to $4.65 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The shares subject to the option are fully vested and exercisable.